Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03218345
What this trial is testing

EUS-guided RFA for Pancreatic Neoplasms

Who this might be right for
Pancreatic Neoplasms
Chinese University of Hong Kong 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07124195
What this trial is testing

Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

Who this might be right for
Malignant Solid TumorsModerate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
The First Affiliated Hospital of Xinxiang Medical College 126
Not applicableStudy completedNCT03109639
What this trial is testing

Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions

Who this might be right for
Solid TumorHistological Type of Neoplasm
Singapore General Hospital 36
Not applicableEnded earlyNCT00507572
What this trial is testing

Collection of Outcomes Data for Pregnant Patients With Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 313
Not applicableNo Longer AvailableNCT03914872
What this trial is testing

Expanded Access Neoantigen Vaccine in Solid Tumors

Who this might be right for
Solid Tumor, Adult
Washington University School of Medicine
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Study completedNCT03551795
What this trial is testing

Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor

Who this might be right for
Malignant Solid Tumor
Xiaoyan Zhang 8
Early research (Phase 1)Study completedNCT02650713
What this trial is testing

The Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 228
Early research (Phase 1)Active Not RecruitingNCT03440450
What this trial is testing

Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer

Who this might be right for
Advanced Solid TumorsBiliary Tract Cancer
Fujifilm Pharmaceuticals U.S.A., Inc. 90
Not applicableLooking for participantsNCT07195513
What this trial is testing

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

Who this might be right for
Palliative Care ReferralAdvanced CancerPalliative Care, Health Services+1 more
Dartmouth-Hitchcock Medical Center 90
Testing effectiveness (Phase 2)Looking for participantsNCT06117540
What this trial is testing

WX390 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd 70
Not applicableStudy completedNCT00255697
What this trial is testing

Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers

Who this might be right for
Psychosocial Effects of Cancer and Its TreatmentUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 863
Not applicableStudy completedNCT04431830
What this trial is testing

Meaning-Centered Pain Coping Skills Training

Who this might be right for
Advanced Solid TumorPain
Duke University 60
Early research (Phase 1)Study completedNCT03441100
What this trial is testing

TCR-engineered T Cells in Solid Tumors: IMA202-101

Who this might be right for
Solid Tumor, AdultRefractory CancerRecurrent Cancer+1 more
Immatics US, Inc. 16
Early research (Phase 1)Study completedNCT05508100
What this trial is testing

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immune-Onc Therapeutics 38
Early research (Phase 1)Study completedNCT01905111
What this trial is testing

BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT04060511
What this trial is testing

HS-10342 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 17
Not applicableEnded earlyNCT05471271
What this trial is testing

IL-2 PET Imaging in Advanced Solid Tumours

Who this might be right for
Metastatic Solid Tumor
University Medical Center Groningen 1
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Next Page